Omeros | OMER - الربح قبل الضريبة





الربح قبل الضريبة تغيير تاريخ
Adma Biologics USD 61.59M 14.07M 2025-12
Alnylam Pharmaceuticals USD 221.65M 60.52M 2026-03
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Cytokinetics USD -183.03M 123.15M 2025-12
Gilead Sciences USD 2.08B 1.56B 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Immunic USD -19.3M 6.28M 2025-12
Insmed USD -326.93M 41.77M 2025-12
Knight Therapeutics CAD -1.92M 13.69M 2025-09
MacroGenics USD -14.93M 31.75M 2025-12
Omeros USD -65.12M 21.27M 2024-06
Pacira USD 571K 8.95M 2025-12
Pfizer USD 5.18B 6.82B 2026-03
Rockwell Medical USD 343K 2.07M 2024-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
United Therapeutics USD 444M 6M 2025-12
Vertex Pharmaceuticals USD 1.33B 32.2M 2025-12
Xoma USD 15.98M 24.58M 2024-06